Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a, Single-Blind, Randomized Comparative Clinical Trial Evaluating the Impact of Vaccine Formulation on the Safety and Immunogenicity of the COV2 Vaccine in Healthy Adults

NCT07416539 is registered in ClinicalTrials.gov with Rokote Laboratories Finland Oy as lead sponsor.

NCT NCT07416539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07416539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a, Single-Blind, Randomized Comparative Clinical Trial Evaluating the Impact of Vaccine Formulation on the Safety and Immunogenicity of the COV2 Vaccine in Healthy Adults
Lead sponsor
Rokote Laboratories Finland Oy
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 10, 2026
Completion date
November 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid - 19, sars cov-2